This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

Too Early to Go for Risk-On Markets?


Visit: Mitrade

Two big risk-on events this week have put a rocket under risk markets.

  1.  President-Elect Joe Biden declaring victory but with possible checks and balances from a Republican Senate, a win-win according to the market.
  2. A COVID-19 vaccine from Pfizer and BioNTech providing very promising results from stage 3 trails.

The surge in risk buying has been going on now since Biden’s lead in major swing states took over (late last Wednesday night). The news that the stage 3 Pfizer/BioNTech trials prevented more than 90% of symptomatic Covid-19 infections in over 40,000 volunteers is not only the most encouraging scientific advance to date, but it’s a sign that 2021 will likely be very different to 2020.

Risk FX initially took all of this as a signal to ‘turn on’ however as time progressed, it was also clear that risk has a dilemma. These positive external factors are over 6 months away from taking effect and possibly 9 months in respect to the COVID-19 vaccine reaching full herd-immunity.

There are some short-term risks that need to be considered.

Second and third waves in the northern hemisphere are reaching new record infection levels, the impact on consumption and confidence will be huge. It may explain why EUR/USD has been patchy even after reaching a 2-month high.


The pair clearly hit a resistance and that looks to be an issue for it going into the long winter months of the Northern Hemisphere. It is not helped by the knock-on from surging US yields.

The other issue is Brexit, the 31 of December is looming large, Westminster is far from united and the EU is running out of patience this could make the end of the year very tricky for the GBP. It is one risk to watch.


Originally Posted on November 12, 2020 – Too Early to Go for Risk-On Markets?

Disclosure: Mitrade

This information has been prepared by Mitrade. In addition to the disclaimer below, Mitrade does not represent that the information provided here is accurate, current or complete, and therefore should not be relied upon as such. This information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Mitrade is not a financial advisor and all services are provided on an execution only basis. We advise any readers of this content to seek their own advice. Reproduction or redistribution of this information is not permitted.

Derivatives trading involves risks and the above information is not suitable for everyone. Refer to our PDS and ensure you understand the risks involved.

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Mitrade and is being posted with permission from Mitrade. The views expressed in this material are solely those of the author and/or Mitrade and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.

Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.

trading top